588 research outputs found

    The Methodology of Me

    Get PDF

    The Voice of Trailing Women in the Decision to Relocate: Is it Really a Choice?

    Get PDF
    The reasons for migration among highly skilled couples are economic as well as noneconomic. However, our understanding of the motivations of trailing wives remains somewhat limited, especially given their loss of personal, professional, and social resources during the relocation. This chapter explores the motivations of women to relocate for their husband’s work. It examines how gender ideologies weave with the decision to relocate, and how women’s considerations and preferences are taken into account during this process. This study included depth interviews with 12 trailing mothers in the Netherlands and in the United States during 2015–2016. Interviews were performed face-to-face or by video chat. The study used an interpretative phenomenological analysis (IPA). Narratives analyses revealed that most trailing wives exerted very limited agency during the decision process and felt that they do not have any realistic alternatives to relocation. This powerlessness was imposed by gender-role ideologies that portray women as the primary care provider and men as the primary breadwinner. Thus, women’s motivations to go overseas were primarily centered on family benefits, such as improving the family’s financial status or supporting their husband’s career. These findings suggest that societal factors, mainly gender, significantly diminish the actual choice options available to trailing wives

    Cognitive Disorders in Patients with Parkinson\u27s Disease on the Background of Autoimmune Pathology

    Full text link
    Parkinson\u27s disease (PD) is a progressive neurodegenerative disease characterized by the predominantly dopaminergic neuronal black matter degeneration. The multicentre study of PRIAMO (PaRkinson & non Motor symptom) showed that in 98.6 % of cases, non-motor symptoms (NMS) were observed in patients with PD. Cognitive impairment is one of the most common NMS PD. According to these studies, cognitive dysfunction develops in most patients at an early stage of the disease, with mild to moderate cognitive impairment. In the later stages of the disease, dementia occurs in 80 % of patients with PD. Aim of the research. To study the peculiarities of cognitive impairment in patients with PD and autoimmune thyroiditis (AIT), their association with motor and non-motor disorders, and to assess the impact on the quality of life of patients.Materials and methods of the research. 109 patients with PD aged 47 to 75 years were examined. The main group consisted of patients with IA and IB subgroups, control – IIA and IIB subgroups. General clinical and neurological examinations, evaluation of motor functions by the Unified Parkinson\u27s disease Rating Scale (UPDRS), neuropsychological testing (MMSE, MoCA, FAB, BDI), Hamilton\u27s Alert Scale (HARS), scale used for assessing autonomic disorders in patients with PD and Parkinson\u27s disease questionnaire (PDQ-39), statistical analysis using the "Statistica 6.0" program.Results. Neuropsychological testing showed that MMSE, MoCA, and FAB obtained from patients with PD and AIT are lower compared to patients with PD. Analyzing the indicators of MMSE, FAB, and MoCA scales in dynamics, a statistically significant difference was found in subgroups of IB and IIB; in subgroups of IA and IIA – was not observed. During the analysis of the results of the neuropsychological testing, no association was found at the statistically significant level in the subgroups of IA and IB between the duration of the disease and MMSE, MoCA, and FAB scales. In the IA subgroup, in the initial review, feedback was observed on a statistically significant level of average strength between the level of anxiety and the indicator of the MMSE scale, an indicator of the MoCA scale. In the IA subgroup, there was no relationship at the statistically significant level between the indicators of neuropsychological testing (MMSE, MoCA, FAB) and motor and non-motor manifestations (depression, vegetative disorders). There was a connection at a statistically significant level between the indicators of neuropsychological testing (MMSE, MoCA, FAB) and motor and non-motor manifestations of PD in patients who received anti-parkinsonian therapy for a long period of time. The negative influence of the level of cognitive impairments on the quality of life of patients with PD and AIT was revealed, indicating the high medical and social significance of these violations.Conclusions. Neuropsychological testing showed that MMSE, MoCA, FAB scores in patients with PD and AIT (IB subgroup) were lower compared to patients with PD (IIB subgroup). There was a connection at a statistically significant level between the indicators of neuropsychological testing (MMSE, MoCA, FAB) and motor and non-motor manifestations of PD in patients who received anti-parkinsonian therapy for a long period of time. The negative influence of the level of cognitive impairments on the quality of life of patients with PD and AIT was revealed, indicating the high medical and social significance of these violations

    2-limited broadcast domination in grid graphs

    Full text link
    We establish upper and lower bounds for the 2-limited broadcast domination number of various grid graphs, in particular the Cartesian product of two paths, a path and a cycle, and two cycles. The upper bounds are derived by explicit constructions. The lower bounds are obtained via linear programming duality by finding lower bounds for the fractional 2-limited multipacking numbers of these graphs

    COGNITIVE DISORDERS IN PATIENTS WITH PARKINSON'S DISEASE ON THE BACKGROUND OF AUTOIMMUNE PATHOLOGY

    Get PDF
    Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by the predominantly dopaminergic neuronal black matter degeneration. The multicentre study of PRIAMO (PaRkinson & non Motor symptom) showed that in 98.6 % of cases, non-motor symptoms (NMS) were observed in patients with PD. Cognitive impairment is one of the most common NMS PD. According to these studies, cognitive dysfunction develops in most patients at an early stage of the disease, with mild to moderate cognitive impairment. In the later stages of the disease, dementia occurs in 80 % of patients with PD. Aim of the research. To study the peculiarities of cognitive impairment in patients with PD and autoimmune thyroiditis (AIT), their association with motor and non-motor disorders, and to assess the impact on the quality of life of patients. Materials and methods of the research. 109 patients with PD aged 47 to 75 years were examined. The main group consisted of patients with IA and IB subgroups, control – IIA and IIB subgroups. General clinical and neurological examinations, evaluation of motor functions by the Unified Parkinson's disease Rating Scale (UPDRS), neuropsychological testing (MMSE, MoCA, FAB, BDI), Hamilton's Alert Scale (HARS), scale used for assessing autonomic disorders in patients with PD and Parkinson’s disease questionnaire (PDQ-39), statistical analysis using the "Statistica 6.0" program. Results. Neuropsychological testing showed that MMSE, MoCA, and FAB obtained from patients with PD and AIT are lower compared to patients with PD. Analyzing the indicators of MMSE, FAB, and MoCA scales in dynamics, a statistically significant difference was found in subgroups of IB and IIB; in subgroups of IA and IIA – was not observed. During the analysis of the results of the neuropsychological testing, no association was found at the statistically significant level in the subgroups of IA and IB between the duration of the disease and MMSE, MoCA, and FAB scales. In the IA subgroup, in the initial review, feedback was observed on a statistically significant level of average strength between the level of anxiety and the indicator of the MMSE scale, an indicator of the MoCA scale. In the IA subgroup, there was no relationship at the statistically significant level between the indicators of neuropsychological testing (MMSE, MoCA, FAB) and motor and non-motor manifestations (depression, vegetative disorders). There was a connection at a statistically significant level between the indicators of neuropsychological testing (MMSE, MoCA, FAB) and motor and non-motor manifestations of PD in patients who received anti-parkinsonian therapy for a long period of time. The negative influence of the level of cognitive impairments on the quality of life of patients with PD and AIT was revealed, indicating the high medical and social significance of these violations. Conclusions. Neuropsychological testing showed that MMSE, MoCA, FAB scores in patients with PD and AIT (IB subgroup) were lower compared to patients with PD (IIB subgroup). There was a connection at a statistically significant level between the indicators of neuropsychological testing (MMSE, MoCA, FAB) and motor and non-motor manifestations of PD in patients who received anti-parkinsonian therapy for a long period of time. The negative influence of the level of cognitive impairments on the quality of life of patients with PD and AIT was revealed, indicating the high medical and social significance of these violations

    The methylated way to translation

    Get PDF

    Exacerbation of hypereosinophilic syndrome with pulmonary involvement in two consecutive pregnancies: a case report and review of the literature

    Get PDF
    Hypereosinophilic syndrome represents a heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and organ system dysfunction including the pulmonary system. Hypereosinophilic syndrome, with and without pulmonary involvement, in association with pregnancy is very rare, and to the best of our knowledge only one case of hypereosinophilic syndrome with pulmonary involvement during pregnancy has been previously reported in the medical literature. We describe a case of a patient with previously symptomatic hypereosinophilic syndrome with pulmonary involvement who experienced exacerbations of her disease during two consecutive pregnancies. To the best of our knowledge this is the first report which demonstrates a worsening effect of pregnancy on both eosinophil count and end organ involvement in a patient with previous diagnosis of hypereosinophilic syndrome

    Thermal and luminescent properties of M2Zn(VO3) 4 (M = Rb, Cs)

    Full text link
    We have developed processes for the synthesis of the Rb 2Zn(VO3)4 and Cs2Zn(VO 3)4 tetrametavanadates. Rb2Zn(VO 3)4 has been prepared by solid-state reaction (350 C) between presynthesized RbVO3 and ZnV2O6 powders, and Cs2Zn(VO3)4 has been prepared by the Pechini method (sol-gel process). Both metavanadates crystallize in monoclinic symmetry (sp. gr. P21/m). Thermochemical characterization results demonstrate that the vanadates undergo complex transformations during heating to 450 C and subsequent cooling. As a result, the materials are in a nonequilibrium state at room temperature and consist of both the parent double metavanadates and their peritectic decomposition products. We believe that the formation of the structure of the M2Zn(VO3)4 compounds from their melts is a kinetically hindered process. These compounds are structurally stable only at temperatures below 369 (Rb2Zn(VO 3)4) or 420 C (Cs2Zn(VO3) 4). We have measured for the first time the diffuse reflectance and photoluminescence excitation spectra of the two tetrametavanadates in their emission range and their photoluminescence spectra at various excitation wavelengths and determined their chromaticity coordinates. Their X-ray luminescence and scintillation decay characteristics have been determined for the first time under pulsed electron beam excitation. The electron excitation dissipation processes in the cesium and rubidium compounds are shown to be similar. We discuss the origin of the emission bands in the mixed vanadates and their potential application areas. © 2013 Pleiades Publishing, Ltd
    corecore